VP
venBio Partners’s Pharvaris PHVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $75.5M | Hold |
4,289,304
| – | – | 65.78% | 1 |
|
2025
Q1 | $67.3M | Hold |
4,289,304
| – | – | 54.5% | 1 |
|
2024
Q4 | $82.2M | Hold |
4,289,304
| – | – | 48.17% | 1 |
|
2024
Q3 | $79.4M | Hold |
4,289,304
| – | – | 40.88% | 1 |
|
2024
Q2 | $80.6M | Hold |
4,289,304
| – | – | 34.83% | 1 |
|
2024
Q1 | $99.1M | Sell |
4,289,304
-630,200
| -13% | -$14.6M | 35.17% | 2 |
|
2023
Q4 | $138M | Buy |
4,919,504
+654,832
| +15% | +$18.4M | 20.68% | 3 |
|
2023
Q3 | $89M | Hold |
4,264,672
| – | – | 25.24% | 2 |
|
2023
Q2 | $64.6M | Buy |
4,264,672
+1,986,097
| +87% | +$30.1M | 23.37% | 3 |
|
2023
Q1 | $18.4M | Sell |
2,278,575
-18,135
| -0.8% | -$146K | 10.17% | 4 |
|
2022
Q4 | $25.8M | Hold |
2,296,710
| – | – | 8.01% | 4 |
|
2022
Q3 | $17.6M | Sell |
2,296,710
-4,741
| -0.2% | -$36.4K | 4.08% | 6 |
|
2022
Q2 | $50.9M | Sell |
2,301,451
-1,859
| -0.1% | -$41.1K | 14.48% | 4 |
|
2022
Q1 | $41.8M | Hold |
2,303,310
| – | – | 9.26% | 4 |
|
2021
Q4 | $33.1M | Hold |
2,303,310
| – | – | 5.97% | 5 |
|
2021
Q3 | $40.8M | Hold |
2,303,310
| – | – | 4.07% | 4 |
|
2021
Q2 | $42.9M | Hold |
2,303,310
| – | – | 5.06% | 4 |
|
2021
Q1 | $64.4M | Buy |
+2,303,310
| New | +$64.4M | 6.12% | 4 |
|